Percutaneous Coronary Intervention (PCI) Overview
Learn About Percutaneous Coronary Intervention (PCI)
Affinity Cardiovascular Specialists LLC
Mark Sasse is an Interventional Cardiologist and a Cardiologist in Birmingham, Alabama. Dr. Sasse and is rated as an Experienced provider by MediFind in Percutaneous Coronary Intervention (PCI). His top areas of expertise are Aortic Valve Stenosis, Angina, End-Stage Renal Disease (ESRD), Transcatheter Aortic Valve Replacement (TAVR), and Aortic Valve Replacement. Dr. Sasse is currently accepting new patients.
William Hillegass is a Cardiologist in Birmingham, Alabama. Dr. Hillegass and is rated as a Distinguished provider by MediFind in Percutaneous Coronary Intervention (PCI). His top areas of expertise are Necrosis, Heart Attack, Coronary Heart Disease, Percutaneous Coronary Intervention (PCI), and Angioplasty.
Massoud Leesar is an Interventional Cardiologist and a Cardiologist in Birmingham, Alabama. Dr. Leesar and is rated as an Advanced provider by MediFind in Percutaneous Coronary Intervention (PCI). His top areas of expertise are Coronary Heart Disease, Heart Attack, Atherosclerosis, Percutaneous Coronary Intervention (PCI), and Angioplasty. Dr. Leesar is currently accepting new patients.
Summary: The aim of this work is to study the role of intracoronary adrenaline administration as a preventive tool for no reflow in patients undergoing primary PCI. The main question it aims to answer is: If prohylcatic intrcoronary adrenaline reduce the incidence of no reflow without increaing risk of arrhythmia in primary PCI? The procedure will be performed by expert operators. All patients will receive...
Summary: 'Heart attack', known as acute ST-segment elevation myocardial infarction, is a leading cause of heart failure and death. A lack of blood and oxygen damages the heart muscle potentially causing heart failure and premature death. During the past 25 years, despite intensive research efforts, few, if any new medicines have been shown to prevent heart failure after a heart attack. New treatment approa...